BioCentury
ARTICLE | Company News

Inflazyme inflammation, neurology news

August 25, 2008 7:00 AM UTC

The company exited the pharmaceutical business. It had sold its remaining compounds to Biolipox AB last year. Biolipox was acquired by Orexo AB (SSE:ORX, Uppsala, Sweden) (see BioCentury, Oct. 1, 20...